株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

白内障手術装置市場:医療機器のパイプライン評価

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015

発行 GlobalData 商品コード 227697
出版日 ページ情報 英文 381 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
白内障手術装置市場:医療機器のパイプライン評価 Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015
出版日: 2015年12月09日 ページ情報: 英文 381 Pages
概要

当レポートでは、世界の白内障手術装置の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 白内障手術装置市場の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 白内障手術装置:治験中のパイプライン製品 (企業別)

  • 白内障手術装置の企業:治験段階別のパイプライン製品
  • 白内障手術装置:治験段階別のパイプライン製品

第5章 白内障手術装置市場:企業・製品の概要

  • Abbott Medical Optics, Inc.
    • パイプライン製品および進行中の治験の概要
  • Adoptics AG
  • Advanced Refractive Technologies, Inc.
  • AkkoLens International BV
  • Alcon, Inc.
  • Altacor Limited
  • Anew Optics, Inc.
  • Bausch & Lomb Incorporated
  • Calhoun Vision, Inc.
  • Elenza, Inc.
  • Eye Care and Cure
  • EyeKon Medical, Inc.
  • Glaukos Corporation
  • Hoya Surgical Optics, Inc.
  • HumanOptics AG
  • Imperial Medical Technologies, Inc
  • InnFocus LLC
  • Innovia LLC
  • International Biomedical
  • LensGen, Inc.
  • London Eye Hospital Pharma
  • Massachusetts Institute of Technology
  • Meir Medical Center
  • Morcher Gmbh
  • Mynosys Cellular Devices, Inc.
  • NuLens Ltd.
  • Oculentis GmbH
  • OptMed, Inc.
  • OptoLight Vision Technology
  • Paradigm Medical Industries, Inc.
  • PowerVision, Inc.
  • Presbeasy
  • Rayner Intraocular Lenses Limited
  • Rhexis Biomedical
  • Sharklet Technologies, Inc.
  • STAAR Surgical Company
  • Tear Diagno LLC
  • TEKIA, Inc.
  • University of Florida
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Visioneering Technologies, Inc.
  • Wake Forest Baptist Medical Center
  • Washington University in St. Louis
  • Xend
  • Z Lens LLC
  • Ziemer Ophthalmic Systems AG

第6章 白内障手術装置市場:昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0124EPD

GlobalData's Medical Devices sector report, "Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cataract Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cataract Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 19

2 Introduction 20

  • 2.1 Cataract Surgery Devices Overview 20

3 Products under Development 21

  • 3.1 Cataract Surgery Devices - Pipeline Products by Stage of Development 21
  • 3.2 Cataract Surgery Devices - Pipeline Products by Segment 22
  • 3.3 Cataract Surgery Devices - Pipeline Products by Territory 23
  • 3.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
  • 3.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
  • 3.6 Cataract Surgery Devices - Ongoing Clinical Trials 26

4 Cataract Surgery Devices - Pipeline Products under Development by Companies 27

  • 4.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 27
  • 4.2 Cataract Surgery Devices - Pipeline Products by Stage of Development 29

5 Cataract Surgery Devices Companies and Product Overview 37

  • 5.1 Abbott Medical Optics, Inc. Company Overview 37
    • 5.1.1 Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.2 Adoptics AG Company Overview 45
    • 5.2.1 Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.3 Advanced Refractive Technologies, Inc. Company Overview 46
    • 5.3.1 Advanced Refractive Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.4 AkkoLens International BV Company Overview 49
    • 5.4.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.5 Alcon, Inc. Company Overview 50
    • 5.5.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.6 Altacor Limited Company Overview 65
    • 5.6.1 Altacor Limited Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.7 Anew Optics, Inc. Company Overview 66
    • 5.7.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.8 Bausch & Lomb Incorporated Company Overview 67
    • 5.8.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.9 Calhoun Vision, Inc. Company Overview 70
    • 5.9.1 Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.10 Elenza, Inc. Company Overview 72
    • 5.10.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.11 Eye Care and Cure Company Overview 73
    • 5.11.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.12 EyeKon Medical, Inc. Company Overview 74
    • 5.12.1 EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.13 Glaukos Corporation Company Overview 230
    • 5.13.1 Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 230
  • 5.14 Hoya Surgical Optics, Inc. Company Overview 234
    • 5.14.1 Hoya Surgical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 234
  • 5.15 HumanOptics AG Company Overview 235
    • 5.15.1 HumanOptics AG Pipeline Products & Ongoing Clinical Trials Overview 235
  • 5.16 Imperial Medical Technologies, Inc Company Overview 239
    • 5.16.1 Imperial Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 239
  • 5.17 InnFocus LLC Company Overview 242
    • 5.17.1 InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 242
  • 5.18 Innovia LLC Company Overview 243
    • 5.18.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 243
  • 5.19 International Biomedical Company Overview 244
    • 5.19.1 International Biomedical Pipeline Products & Ongoing Clinical Trials Overview 244
  • 5.20 LensGen, Inc. Company Overview 246
    • 5.20.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
  • 5.21 London Eye Hospital Pharma Company Overview 247
    • 5.21.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview 247
  • 5.22 Massachusetts Institute of Technology Company Overview 248
    • 5.22.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 248
  • 5.23 Meir Medical Center Company Overview 249
    • 5.23.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 249
  • 5.24 Morcher Gmbh Company Overview 250
    • 5.24.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 250
  • 5.25 Mynosys Cellular Devices, Inc. Company Overview 285
    • 5.25.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 285
  • 5.26 NuLens Ltd. Company Overview 286
    • 5.26.1 NuLens Ltd. Pipeline Products & Ongoing Clinical Trials Overview 286
  • 5.27 Oculentis GmbH Company Overview 288
    • 5.27.1 Oculentis GmbH Pipeline Products & Ongoing Clinical Trials Overview 288
  • 5.28 OptMed, Inc. Company Overview 290
    • 5.28.1 OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 290
  • 5.29 OptoLight Vision Technology Company Overview 291
    • 5.29.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 291
  • 5.30 Paradigm Medical Industries, Inc. Company Overview 292
    • 5.30.1 Paradigm Medical Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview 292
  • 5.31 PowerVision, Inc. Company Overview 293
    • 5.31.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 293
  • 5.32 Presbeasy Company Overview 297
    • 5.32.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 297
  • 5.33 Rayner Intraocular Lenses Limited Company Overview 298
    • 5.33.1 Rayner Intraocular Lenses Limited Pipeline Products & Ongoing Clinical Trials Overview 298
  • 5.34 Rhexis Biomedical Company Overview 317
    • 5.34.1 Rhexis Biomedical Pipeline Products & Ongoing Clinical Trials Overview 317
  • 5.35 Sharklet Technologies, Inc. Company Overview 318
    • 5.35.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 318
  • 5.36 STAAR Surgical Company Company Overview 319
    • 5.36.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 319
  • 5.37 Tear Diagno LLC Company Overview 324
    • 5.37.1 Tear Diagno LLC Pipeline Products & Ongoing Clinical Trials Overview 324
  • 5.38 TEKIA, Inc. Company Overview 325
    • 5.38.1 TEKIA, Inc. Pipeline Products & Ongoing Clinical Trials Overview 325
  • 5.39 University of Florida Company Overview 326
    • 5.39.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 326
  • 5.40 University of Rochester Company Overview 327
    • 5.40.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 327
  • 5.41 University of Texas Medical Branch at Galveston Company Overview 328
    • 5.41.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 328
  • 5.42 Visioneering Technologies, Inc. Company Overview 329
    • 5.42.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 329
  • 5.43 Wake Forest Baptist Medical Center Company Overview 330
    • 5.43.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 330
  • 5.44 Washington University in St. Louis Company Overview 331
    • 5.44.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 331
  • 5.45 Xend Company Overview 332
    • 5.45.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 332
  • 5.46 Z Lens LLC Company Overview 333
    • 5.46.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 333
  • 5.47 Ziemer Ophthalmic Systems AG Company Overview 334
    • 5.47.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 334

6 Cataract Surgery Devices- Recent Developments 338

7 Appendix 378

  • 7.1 Methodology 378
  • 7.2 About GlobalData 380
  • 7.3 Contact Us 381
  • 7.4 Disclaimer 381

List of Tables

  • Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 21
  • Table 2: Cataract Surgery Devices - Pipeline Products by Segment 22
  • Table 3: Cataract Surgery Devices - Pipeline Products by Territory 23
  • Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
  • Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
  • Table 6: Cataract Surgery Devices - Ongoing Clinical Trials 26
  • Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 27
  • Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development 29
  • Table 9: Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 10: Enhanced Phacoemulsification System - Product Status 38
  • Table 11: Enhanced Phacoemulsification System - Product Description 38
  • Table 12: Intraocular Lens - Astigmatism - Product Status 39
  • Table 13: Intraocular Lens - Astigmatism - Product Description 39
  • Table 14: Intraocular Lens - Presbyopia - Product Status 40
  • Table 15: Intraocular Lens - Presbyopia - Product Description 40
  • Table 16: Modified Light Transmission IOL - Product Status 41
  • Table 17: Modified Light Transmission IOL - Product Description 41
  • Table 18: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Status 42
  • Table 19: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Description 42
  • Table 20: TECNIS-1 Monofocal IOL - Product Status 43
  • Table 21: TECNIS-1 Monofocal IOL - Product Description 43
  • Table 22: Unfolder Platinum 1 - Product Status 44
  • Table 23: Unfolder Platinum 1 - Product Description 44
  • Table 24: Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 25: Shape-Changing Accommodating Intraocular Lens - Product Status 45
  • Table 26: Shape-Changing Accommodating Intraocular Lens - Product Description 45
  • Table 27: Advanced Refractive Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 28: Accupulse Cataract Emulsifier - Product Status 47
  • Table 29: Accupulse Cataract Emulsifier - Product Description 47
  • Table 30: Lens Opacity Threshold System - Product Status 48
  • Table 31: Lens Opacity Threshold System - Product Description 48
  • Table 32: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 33: AkkoLens AIOL - Product Status 49
  • Table 34: AkkoLens AIOL - Product Description 49
  • Table 35: Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 36: Accommodative Intraocular Lens - Product Status 51
  • Table 37: Accommodative Intraocular Lens - Product Description 51
  • Table 38: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 52
  • Table 39: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 52
  • Table 40: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Status 53
  • Table 41: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Description 53
  • Table 42: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 54
  • Table 43: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 54
  • Table 44: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 55
  • Table 45: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 55
  • Table 46: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Status 56
  • Table 47: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Description 56
  • Table 48: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Status 57
  • Table 49: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Description 57
  • Table 50: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 58
  • Table 51: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 58
  • Table 52: AcrySof IQ Toric Diopter Range Expansion - Product Status 59
  • Table 53: AcrySof IQ Toric Diopter Range Expansion - Product Description 59
  • Table 54: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 60
  • Table 55: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 60
  • Table 56: Intrepid IOL - Product Status 61
  • Table 57: Intrepid IOL - Product Description 61
  • Table 58: LenSx Laser System Expansion - Product Status 62
  • Table 59: LenSx Laser System Expansion - Product Description 62
  • Table 60: Alcon, Inc. - Ongoing Clinical Trials Overview 63
  • Table 61: AcrySof IQ ReSTOR Multifocal Toric Lens - Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye 64
  • Table 62: Altacor Limited Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 63: SOLO - Product Status 65
  • Table 64: SOLO - Product Description 65
  • Table 65: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 66: Zephyr Lens - Product Status 66
  • Table 67: Zephyr Lens - Product Description 66
  • Table 68: Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 69: Cirle 3-D Surgical Navigation System - Product Status 68
  • Table 70: Cirle 3-D Surgical Navigation System - Product Description 68
  • Table 71: Sarfarazi Elliptical Accommodating IOL - Product Status 69
  • Table 72: Sarfarazi Elliptical Accommodating IOL - Product Description 69
  • Table 73: Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 74: Light Adjustable Lens - Product Status 71
  • Table 75: Light Adjustable Lens - Product Description 71
  • Table 76: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 77: Sapphire Autofocal IOL - Product Status 72
  • Table 78: Sapphire Autofocal IOL - Product Description 72
  • Table 79: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 80: Ophthalmic Device - Cataract Surgery - Product Status 73
  • Table 81: Ophthalmic Device - Cataract Surgery - Product Description 73
  • Table 82: EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 83: AcuGel Plus Viscoelastics - Product Status 78
  • Table 84: AcuGel Plus Viscoelastics - Product Description 78
  • Table 85: AcuGel SH Viscoelastics - Product Status 79
  • Table 86: AcuGel SH Viscoelastics - Product Description 79
  • Table 87: AcuGel Viscoelastics - Product Status 80
  • Table 88: AcuGel Viscoelastics - Product Description 80
  • Table 89: Acuity 1 Disposable Injector - Product Status 81
  • Table 90: Acuity 1 Disposable Injector - Product Description 81
  • Table 91: Acuity Capsular Tension Ring 10mm - Product Status 82
  • Table 92: Acuity Capsular Tension Ring 10mm - Product Description 82
  • Table 93: Acuity Capsular Tension Ring 12mm - Product Status 83
  • Table 94: Acuity Capsular Tension Ring 12mm - Product Description 83
  • Table 95: ACUITY FA55A-4NY IOL - Product Status 84
  • Table 96: ACUITY FA55A-4NY IOL - Product Description 84
  • Table 97: Acuity FA55A-4UV IOL - Product Status 85
  • Table 98: Acuity FA55A-4UV IOL - Product Description 85
  • Table 99: Acuity FB25B - UV IOL - Product Status 86
  • Table 100: Acuity FB25B - UV IOL - Product Description 86
  • Table 101: Acuity FB25B-NY IOL - Product Status 87
  • Table 102: Acuity FB25B-NY IOL - Product Description 87
  • Table 103: Acuity FS25B-NY IOL - Product Status 88
  • Table 104: Acuity FS25B-NY IOL - Product Description 88
  • Table 105: Acuity FS25B-UV IOL - Product Status 89
  • Table 106: Acuity FS25B-UV IOL - Product Description 89
  • Table 107: Acuity FS60S - 4NY IOL - Product Status 90
  • Table 108: Acuity FS60S - 4NY IOL - Product Description 90
  • Table 109: Acuity FS60S - 4UV IOL - Product Status 91
  • Table 110: Acuity FS60S - 4UV IOL - Product Description 91
  • Table 111: Acuity SB25B IOL - Product Status 92
  • Table 112: Acuity SB25B IOL - Product Description 92
  • Table 113: Acuity SB25B-NY IOL - Product Status 93
  • Table 114: Acuity SB25B-NY IOL - Product Description 93
  • Table 115: Acuity TN60 - 2NY IOL - Product Status 94
  • Table 116: Acuity TN60 - 2NY IOL - Product Description 94
  • Table 117: Acuity TN60-OUV IOL - Product Status 95
  • Table 118: Acuity TN60-OUV IOL - Product Description 95
  • Table 119: Acuity UB60-0UV IOL - Product Status 96
  • Table 120: Acuity UB60-0UV IOL - Product Description 96
  • Table 121: Acuity UY60 - OUV IOL - Product Status 97
  • Table 122: Acuity UY60 - OUV IOL - Product Description 97
  • Table 123: Acurus AA55A-41 IOL - Product Status 98
  • Table 124: Acurus AA55A-41 IOL - Product Description 98
  • Table 125: Acurus AA55A-44 IOL - Product Status 99

List of Figures

  • Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 21
  • Figure 2: Cataract Surgery Devices - Pipeline Products by Segment 22
  • Figure 3: Cataract Surgery Devices - Pipeline Products by Territory 23
  • Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 24
  • Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 25
  • Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials 26
Back to Top